Quart Barry D plan to sell securities of Kiniksa Pharmaceuticals International, plc under Form 144

Quart Barry D filed Form 144 to notify SEC of plan to sell 20000 units of Kiniksa Pharmaceuticals International, plc securities around 2026-04-06, with aggregate market value of $1,000,000.00. The total outstanding units is 45900637.0. The amount planned to be sold represents 0.04% of total outstanding units; Recent transactions in past 3 months include: On 02/02/2026, sold 830 units for $37354.00; On 02/03/2026, sold 12528 units for $567136.00; On 02/04/2026, sold 2602 units for $117138.00; On 02/10/2026, sold 110 units for $4950.00; On 02/12/2026, sold 2690 units for $121050.00;